Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Michael

Showing results (641-650 of 652) with videos related to

Pageof 66
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 9, 2009
National hand hygiene campaigns in Europe, 2000-2009A P Magiorakos, C Suetens, L Boyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with CrizotinibEzra Y Rosen, Melissa L Johnson, Sarah E Clifford, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2020
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven MalignanciesBenjamin J Solomon, Lavinia Tan, Jessica J Lin, et al.
Cancer Discovery|May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose EscalationRona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Cancer Discovery|June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid TumorsAlexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
The New England Journal of Medicine|August 27, 2020
Efficacy of Selpercatinib in <i>RET</i>-Altered Thyroid CancersLori J Wirth, Eric Sherman, Bruce Robinson, et al.
The New England Journal of Medicine|August 27, 2020
Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small-Cell Lung CancerAlexander Drilon, Geoffrey R Oxnard, Daniel S W Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2014
Goniometer-based femtosecond crystallography with X-ray free electron lasersAina E Cohen, S Michael Soltis, Ana González, et al.
Structure (London, England : 1993)|March 22, 2016
Acoustic Injectors for Drop-On-Demand Serial Femtosecond CrystallographyChristian G Roessler, Rakhi Agarwal, Marc Allaire, et al.
Gastroenterology|April 28, 2012
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi processCathy Bennett, Nimish Vakil, Jacques Bergman, et al.
Pageof 66

Showing results (641-650 of 652) with videos related to

Sort By:
Pageof 66
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 9, 2009
National hand hygiene campaigns in Europe, 2000-2009A P Magiorakos, C Suetens, L Boyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with CrizotinibEzra Y Rosen, Melissa L Johnson, Sarah E Clifford, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2020
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven MalignanciesBenjamin J Solomon, Lavinia Tan, Jessica J Lin, et al.
Cancer Discovery|May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose EscalationRona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Cancer Discovery|June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid TumorsAlexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
The New England Journal of Medicine|August 27, 2020
Efficacy of Selpercatinib in <i>RET</i>-Altered Thyroid CancersLori J Wirth, Eric Sherman, Bruce Robinson, et al.
The New England Journal of Medicine|August 27, 2020
Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small-Cell Lung CancerAlexander Drilon, Geoffrey R Oxnard, Daniel S W Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2014
Goniometer-based femtosecond crystallography with X-ray free electron lasersAina E Cohen, S Michael Soltis, Ana González, et al.
Structure (London, England : 1993)|March 22, 2016
Acoustic Injectors for Drop-On-Demand Serial Femtosecond CrystallographyChristian G Roessler, Rakhi Agarwal, Marc Allaire, et al.
Gastroenterology|April 28, 2012
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi processCathy Bennett, Nimish Vakil, Jacques Bergman, et al.
Pageof 66